ArriVent BioPharma Statistics

Total Valuation

AVBP has a market cap or net worth of $732.07 million. The enterprise value is $495.46 million.

Market Cap	732.07M
Enterprise Value	495.46M

Important Dates

The last earnings date was Monday, August 11, 2025, before market open.

Earnings Date	Aug 11, 2025
Ex-Dividend Date	n/a

Share Statistics

AVBP has 40.57 million shares outstanding. The number of shares has increased by 113.42% in one year.

Current Share Class	40.57M
Shares Outstanding	40.57M
Shares Change (YoY)	+113.42%
Shares Change (QoQ)	+3.27%
Owned by Insiders (%)	2.23%
Owned by Institutions (%)	49.81%
Float	24.04M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	2.70
P/TBV Ratio	2.93
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 12.74, with a Debt / Equity ratio of 0.00.

Current Ratio	12.74
Quick Ratio	12.03
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -50.06% and return on invested capital (ROIC) is -24.76%.

Return on Equity (ROE)	-50.06%
Return on Assets (ROA)	-23.41%
Return on Invested Capital (ROIC)	-24.76%
Return on Capital Employed (ROCE)	-43.36%
Revenue Per Employee	n/a
Profits Per Employee	-$2.63M
Employee Count	52
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -19.44% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-19.44%
50-Day Moving Average	21.58
200-Day Moving Average	23.76
Relative Strength Index (RSI)	36.68
Average Volume (20 Days)	298,104

Short Selling Information

The latest short interest is 6.09 million, so 15.02% of the outstanding shares have been sold short.

Short Interest	6.09M
Short Previous Month	5.80M
Short % of Shares Out	15.02%
Short % of Float	25.34%
Short Ratio (days to cover)	20.83

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-108.33M
Pretax Income	n/a
Net Income	-136.79M
EBITDA	n/a
EBIT	-108.33M
Earnings Per Share (EPS)	-$4.02

Full Income Statement

Balance Sheet

The company has $235.69 million in cash and $98,000 in debt, giving a net cash position of $235.59 million or $5.81 per share.

Cash & Cash Equivalents	235.69M
Total Debt	98,000
Net Cash	235.59M
Net Cash Per Share	$5.81
Equity (Book Value)	249.87M
Book Value Per Share	6.66
Working Capital	230.51M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-126.63M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

AVBP does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-113.42%
Shareholder Yield	-113.42%
Earnings Yield	-18.71%
FCF Yield	n/a

Analyst Forecast

The average price target for AVBP is $38.25, which is 111.97% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$38.25
Price Target Difference	111.97%
Analyst Consensus	Strong Buy
Analyst Count	8
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1